News By Tag
News By Place
Bionetworks: reviewing the collaborations between pharma, biotech, academia and venture capitalists
As many pharmaceutical companies’ needs for growing their pipelines rise, this is fuelling the increase in partnerships with external groups – academia, biotech and funding organisations.
Based on this information, the SMi Group is delighted to introduce its inaugural European Bionetworks Summit, taking place in London, UK, on the 7th and 8th of July 2014. The event programme includes timely case studies, presentations, roundtables and panel discussions on the hottest topics, delivered by leading industry experts as they demonstrate how to create winning strategic partnerships from modern day collaborations. This unique event will create the perfect platform for Pharmaceutical, Biotech, Academia and Venture Capitalists to discuss the importance of creating winning strategic partnerships.
Event speakers include: Sanj Singh (President & CEO), AdeTherapeutics Inc; Mika Partanen (Deputy Director, Global Competitive Insights) Bayer Pharma; Robert Williams (Chief Development Scientist, Drug Development Office), Cancer Research UK; Jorgen Drejer (Chief Executive Officer), Aniona; Timothy Herpin (Head of Transactions (UK), Business Development)
Interactive half-day post-conference workshop (http://www.smi-
For more information about this event please go to http://www.smi-
Sponsorship enquiries, please contact Alia Malick, Director, on +44(0) 207 827 6168 or e-mail amalick@smi-
Contact Sajid Goraya on +44(0) 207 827 6148 or e-mail sgoraya@smi-
Contact for media-partners: